Report of Foreign Issuer (6-k)
September 06 2018 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2018
Commission File Number 001-37381
MEDIGUS
LTD.
(Translation
of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY NOTE
On
September 6, 2018, the Company received a position statement from L.I.A. Pure Capital Ltd. in connection with the Company’s annual
general meeting to be convened on September 20, 2018. A copy of this position statement is furnished herewith as exhibit 99.1.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
MEDIGUS LTD.
|
|
|
|
Date: September 6, 2018
|
By:
|
/s/ Oded Yatzkan
|
|
|
Oded Yatzkan
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024